//
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
A Novel Algorithm for Treating Chronic Total Coronary Artery Occlusion
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial
Dynamic atrioventricular delay programming improves ventricular electrical synchronization as evaluated by 3D vectorcardiography
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document